In the past years, Kahn Partners and its founders have worked on numerous M&A deals, most of them being cross-border transactions that required advice and expertise at the highest levels.
Acquisition of GenBio by Diaxonhit.
In the second quarter of 2017, Kahn Partners represented Paris-based Diaxonhit in its acquisition of Genbio, a San-Diego based medical diagnostic company. Diaxonhit is a company listed on Euronext in Paris. The transaction, which was financed through, was closed in San Diego after a short four-month multi-level negotiation process. The transaction was handled by Kahn Partners’ San Francisco and Washington D.C. offices.
Confidential M&A transaction by Airbus.
In the first quarter of 2017, Kahn Partners represented Airbus in a confidential M&A transaction that involved business operations on the West Coast of the United States. Kahn Partners’ Washington D.C. and San Francisco offices worked on the matter.
Acquisition of Itelios by Capgemini.
In the first quarter of 2017, Kahn Partners represented Itelios in its sale to Capgemini, a company listed on multiple exchanges. The transaction was the largest ever acquisition in the omnichannel ecommerce in France. Kahn Partners led the transaction over a condensed three month period. The multinational profile of the buyer required that the transaction be conducted as an Anglo-Saxon M&A deal, even though the target was based and operated mainly in France. Kahn Partners worked on the transaction through its team in Paris, Washington D.C. and San Francisco.
Sale of business of Mexel Industries to Taihaimanuer Heyuan.
In the fourth quarter of 2016, Kahn Partners represented Mexel Industries in its sale of its water treatment business to Shangai-based Taihaimanuer Heyuan. The acquisition by the Chinese conglomerate involved multiple regulatory challenges. The transaction was handled by Kahn Partners’ Washington D.C. and Paris offices.
Acquisition of B&H Consulting by Voisin Consulting.
In the fourth quarter of 2015, Kahn Partners represented Voisin Consulting Life Sciences in its acquisition of New Jersey-based B&H Consulting, an experienced regulatory firm that assists pharma and biotech companies facilitate interactions with FDA and navigate FDA regulatory processes.
Other Representative Deals
Extensive representation of publicly traded U.S. defense contractor in merger agreement with major publicly traded U.S. defense company in transaction valued at approximately US$2 billion.
Extensive representation of Saudi Arabian client in significant strategic investments, joint ventures and acquisitions in the United States and Europe in the hotel, entertainment and media industries, ranging from millions of US$ to over US$1 billion.
Representation of French publicly traded online marketing company in US$100 million acquisition of U.S. Internet company (stock and cash).
Extensive representation of dual listed (United States and France) technology company in several transactions, including: the sale of a major subsidiary with world-wide operations to a European publicly traded buyer; the sale of a significant business unit with world-wide operations to a European investment fund; the acquisition of a European technology business unit with world-wide operations; the sale of joint venture interests in technology firm in the Middle East; the “merger of equals” to form new leader in industry.
Representation of major non-U.S. investor in proposed participation in multi billion Euros leveraged buyout of European telecommunication company.
Representation of major non-U.S. investor in connection with sale of significant interest in real estate property in Paris valued at several hundreds of millions of Euros.
Extensive representation of publicly traded international media conglomerate in several investments, including aggregate US$1 billion investment in European media company.
Extensive representation of publicly traded U.S. technology firm in its sale of satellite-based communication network in Africa held through French and Luxembourg entities.
Representation of major publicly traded U.S. automotive company in connection with disposition of multi-billion US$ business assets the U.S. and in Europe.
Representation of major publicly traded U.S. automotive company in connection with disposition of significant U.S. financial assets.
Representation of publicly traded international news and media company in several tax-driven internal restructuring transactions.